INVA
Innoviva, Inc.
Key Financials
Net Income
$4.4M
N/A
Operating Income
$163.7M
↓ 1.9%
Gross Profit
$307.7M
↑ 3.9%
Revenue
$411.3M
↑ 14.7%
Total Assets
$1.6B
↑ 25.7%
Cash & Equivalents
$550.9M
↑ 80.7%
EPS (Diluted)
$3.30
↑ 816.7%
Shareholders' Equity
$1.2B
↑ 69.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INVA |
| Company Name | Innoviva, Inc. |
| CIK | 1080014 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6502389600 |